Picture [LSUS] – The Business Web Portal 600x60px
Organisation › Details

Aptuit (Group)

Aptuit, LLC provides the most complete set of integrated early discovery to mid-phase drug development services in the pharmaceutical industry including Drug Design & Discovery, API Development and Manufacture, Solid State Chemistry, CMC, Preclinical and IND enabling GLP/GMP programs. Fully integrated drug discovery & development services are available from our facilities in the UK, Italy, and now Switzerland. Aptuit, LLC is partnered with Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. *


Period Start 2005-07-05 renamed
  Group Evotec (Group)
  Predecessor Global Pharmaceutical Development Inc.
Product Industry drug development services
Person Person Goldman, Jonathan (Aptuit 201604 CEO)
  Street Two Greenwich Office Park
  City 06831 Greenwich, CT
  Tel +1-203-422-6600
    Address record changed: 2018-07-24
Basic data Employees n. a.
  Currency EUR
  Annual sales 88,000,000 (revenues (2016) 2016-12-31)
    * Document for �About Section�: Aptuit, LLC. (4/21/16). "Press Release: Aptuit Announces Acquisition of Exquiron Biotech AG". Greenwich, CT.
Record changed: 2018-10-31


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Evotec (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top